Our deep knowledge across diverse treatment fields within early and late-stage research allows us to advance your compound efficiently, whether via early, late, or bioanalytical support solutions. As an integrated development pathway or an independent engagement, we embed therapeutic understanding into every activity we deliver. We guide the smooth progression of your compound across all stages of development within each of our therapeutic focus areas, enabling you to reach patients sooner and smarter.
At United Pharmaceuticals Inc., we support the cardiology sector through reliable contract manufacturing of high-quality pharmaceutical ingredients, excipients, machinery, equipment, and packaging materials used in cardiovascular healthcare products.
Our focus is on delivering consistent quality, regulatory compliance, and scalable manufacturing solutions to meet the growing global demand for cardiology formulations. With cardiovascular diseases remaining a leading global health challenge, we are committed to enabling safe, effective, and accessible cardiology products through precision-driven manufacturing and supply expertise.
We partner with pharmaceutical companies to manufacture materials that play a critical role in the development and commercialization of cardiology medicines. Our capabilities are designed to support a wide range of cardiovascular therapeutic needs, including:
Our contract manufacturing solutions are tailored to align with each client’s formulation requirements, scale, and long-term market strategy.
United Pharmaceuticals specializes in the production and supply of pharmaceutical-grade ingredients and excipients suitable for dermatology formulations, including creams, gels, ointments, lotions, and other topical or transdermal systems. Our services help ensure product safety, performance, and patient acceptance.
With increasing demand for safe and effective skin therapies, we are committed to supplying materials that meet stringent quality, safety, and regulatory expectations across topical and systemic dermatology applications.
We play a vital role in enabling dermatology innovation by supplying the materials that form the foundation of effective skin therapies. Our manufacturing capabilities help pharmaceutical companies bring dermatology products to market with confidence, efficiency, and long-term sustainability.
United Pharmaceuticals Inc. focuses on gastroenterology-related manufacturing services designed to support a wide range of formulations used in digestive health and gastrointestinal-related conditions. We work closely with partners to ensure materials are suitable for complex gastrointestinal environments and diverse dosage forms.
Our focus is on enabling safe, effective, and scalable production of products designed to act within the digestive system or systemically through GI delivery.
Each solution is tailored to formulation behavior, stability requirements, and intended route of administration. Our integrated manufacturing approach helps partners reduce sourcing complexity while maintaining high quality and operational reliability.
United Pharmaceuticals Inc. helps pharmaceutical companies produce high-quality hematology products that meet strict safety, performance, and regulatory requirements across global markets. With blood disorders requiring high levels of accuracy and consistency, our manufacturing processes are designed to support therapies where quality cannot be compromised.
Hematology products often demand complex formulation behavior and strict control of material characteristics. United Pharmaceuticals works closely with partners to manufacture materials suitable for a wide range of hematology-focused products, supporting both early-stage and commercial manufacturing needs.
Each manufacturing program is customized based on formulation sensitivity, dosage form, and end-use requirements.
United Pharmaceuticals works with partners to manufacture materials suitable for a wide range of immune-focused therapies, supporting both innovation and scalability. We manufacture pharmaceutical-grade ingredients and excipients designed for immunology formulations where stability, reproducibility, and purity are essential.
Our materials are produced under strict quality systems to support consistent performance across sensitive immune-related applications. Each manufacturing program is tailored to the specific molecular profile, formulation complexity, and intended market.
Through technical expertise and a global manufacturing mindset, we contribute to the advancement of immunology care worldwide.
United Pharmaceuticals Inc. has deep knowledge of regulatory frameworks governing vaccine authorization and strong operational readiness. We are well-positioned to accelerate the development of novel vaccines and delivery technologies. Supported by access to extensive participant pools, our teams have contributed to vaccine programs targeting a broad range of infectious conditions, including:
We manufacture and supply pharmaceutical-grade ingredients and excipients used in infectious disease treatments and vaccine formulations. These materials are produced under stringent quality systems to ensure suitability for sensitive biological and chemical applications.
All materials are manufactured with full traceability and documentation to support global regulatory submissions.
We operate with a strong international supply network, enabling reliable delivery of pharmaceutical materials for infectious disease and vaccine programs worldwide. Our integrated manufacturing and supply model helps partners reduce complexity while maintaining consistent quality across regions.
Packaging formats are selected to meet both regulatory and logistical requirements across global markets.
United Pharmaceuticals Inc. considers neurology a core therapeutic focus supported by deep scientific knowledge and strong technical infrastructure. Our teams have extensive experience contributing to a wide range of neurology-focused programs across both nonclinical and clinical stages, while also supporting formulation development, pharmaceutical manufacturing, and analytical testing activities required for central nervous system products.
We work with both small- and large-molecule neurology therapies, providing integrated support that spans early formulation design through scalable manufacturing solutions. Our capabilities are designed to help sponsors navigate the complexity of CNS development while maintaining product quality, regulatory compliance, and operational efficiency.
By partnering with United Pharmaceuticals as a single, end-to-end provider, companies can streamline their neurology development pathways and significantly reduce timelines by minimizing handoffs between vendors. This integrated approach enables faster progression from concept to commercialization while ensuring consistent quality and regulatory readiness.
United Pharmaceuticals Inc. supports oncology development through specialized scientific and manufacturing capabilities built to address the complexity of modern cancer therapies. Our experience enables oncology compounds to progress efficiently toward clinical readiness while meeting strict quality and regulatory expectations.
Our integrated approach combines formulation expertise, manufacturing readiness, and quality-driven processes to support oncology programs from early development onward. We focus on ensuring that oncology products are developed within controlled systems that prioritize patient safety, product integrity, and regulatory compliance.
By partnering with United Pharmaceuticals, companies can streamline oncology development and reduce operational complexity. Our integrated manufacturing and supply approach helps accelerate the transition from development to commercialization while maintaining consistency, reliability, and regulatory readiness across all stages of the product lifecycle.
United Pharmaceuticals Inc. goes beyond standard clinical chemistry and lipid profiling typically used in metabolic and endocrine research. Our nonclinical capabilities include advanced metabolic assays that provide deeper insight into endocrine function, such as glycated hemoglobin (A1C) testing and specialized metabolic evaluations like glucose tolerance studies to better characterize compound performance in this therapeutic area.
Within the clinical setting, we bring extensive experience supporting early-phase programs for metabolic therapies. Our work includes numerous initial-stage studies involving glucose-lowering and insulin-modulating treatments across diverse patient populations, including individuals with Type I and Type II diabetes, obesity, metabolic syndrome, and non-alcoholic steatohepatitis (NASH).
These programs have encompassed a broad range of proof-of-concept investigations focused on assessing glucose regulation through multiple methodologies. Advanced glucose clamp techniques are employed using high-precision analytical systems such as the YSI-2900, enabling rapid and accurate processing of multiple glucose samples within a single analytical run.
United Pharmaceuticals Inc. supports ophthalmology-focused programs through specialized manufacturing and technical capabilities designed for the unique requirements of ocular therapies. Our experience helps ophthalmic products advance efficiently while maintaining strict standards for quality, safety, and regulatory compliance.
Our end-to-end development model allows ophthalmology programs to progress seamlessly from early formulation concepts through scalable manufacturing stages. We ensure that ophthalmic products are developed under controlled systems that support sterility, stability, and consistent performance.
By working with United Pharmaceuticals as a single, integrated manufacturing and supply partner, companies can simplify ophthalmology development pathways. Our coordinated approach reduces handoffs, improves efficiency, and supports a smoother transition from development to commercialization of ophthalmic products.
At United Pharmaceuticals Inc., we support orthopedic and musculoskeletal development programs with specialized capabilities that help advance therapies targeting bone, joint, and connective tissue disorders. Our experience spans early development stages, enabling efficient progression while maintaining scientific rigor and regulatory readiness.
Our integrated development approach supports a smooth transition from preclinical evaluation to early clinical validation.
By partnering with United Pharmaceuticals Inc., orthopedic programs benefit from a coordinated development model that reduces complexity and accelerates decision-making. Our streamlined processes help move musculoskeletal therapies forward with confidence from early research through proof-of-concept milestones.
Support ophthalmic products with specialized manufacturing processes designed for regulatory acceptance.
Psychiatric drug development demands a careful balance of safety evaluation, behavioral insight, and early clinical readiness. United Pharmaceuticals Inc. provides focused development support for compounds intended to address psychiatric and neurobehavioral conditions, helping sponsors move confidently through early stages of evaluation and validation.
This therapeutic area is supported through a development framework designed to manage complexity while maintaining scientific and regulatory rigor.
Through collaboration with United Pharmaceuticals Inc., psychiatric programs gain access to an integrated development approach that minimizes fragmentation and supports efficient progression. Our teams remain closely aligned with program objectives to ensure continuity as compounds advance through critical milestones.
Facilitate psychiatric therapies with compliant manufacturing solutions prepared for global markets.
Respiratory and pulmonary therapies demand manufacturing precision, contamination control, and strict adherence to regulatory standards. At United Pharmaceuticals Inc., we support the production of respiratory products intended for both locally acting and systemically delivered therapies, with a focus on quality consistency and global regulatory compliance.
Manufacturing support for pulmonary products is structured to address specialized formulation requirements, device compatibility, and tightly controlled processing environments essential for respiratory applications.
Advance respiratory product manufacturing with United Pharmaceuticals Inc. through compliant, scalable solutions designed to support regulatory confidence and long-term supply reliability.
Therapies addressing inflammatory and autoimmune disorders demand a high level of control across pharmaceutical sourcing and manufacturing. Consistency of materials, robust process validation, and adherence to regulatory expectations are essential to supporting products intended for long-term and often systemic use.
United Pharmaceuticals Inc. supports rheumatology-focused programs through the supply of critical pharmaceutical inputs and the operation of controlled manufacturing systems designed for regulated markets. Emphasis is placed on traceability, batch-to-batch reliability, and documentation practices aligned with global compliance frameworks.
Advance rheumatology manufacturing through disciplined processes built to maintain product integrity, regulatory confidence, and continuity of supply across international markets.
Products intended for the treatment of substance use disorders operate under heightened regulatory control and strict manufacturing expectations. At United Pharmaceuticals Inc., operations in this area are structured around secure material handling, controlled processing environments, and documentation practices that support regulatory compliance across global markets.
Manufacturing support extends across multiple dosage forms and delivery approaches, with systems designed to maintain consistency, traceability, and audit readiness throughout the product lifecycle.
Advance substance abuse–related manufacturing through disciplined processes designed to sustain compliance, product integrity, and secure global supply.
Urology-related products often involve long-term administration, sensitive indications, and strict quality requirements. At United Pharmaceuticals Inc., support in this area focuses on the reliable supply of pharmaceutical substances and formulation components, along with controlled manufacturing processes designed to meet regulatory expectations.
Manufacturing operations are structured to support a range of dosage forms commonly used in urology, with emphasis on material consistency, process validation, and documentation suitable for regulatory review.
Advance urology manufacturing through disciplined production practices that support product integrity, compliance, and consistent performance.
Products designed for women’s health often require specialized formulation approaches, sensitive handling, and heightened regulatory oversight due to long-term use and hormone-related considerations. At United Pharmaceuticals Inc., support in this area focuses on the supply of pharmaceutical substances and formulation components, alongside controlled manufacturing processes structured to meet regulatory expectations for women’s health applications.
Manufacturing operations are designed to accommodate diverse administration routes commonly associated with women’s health products, with emphasis on material consistency, validated processes, and documentation suitable for regulatory review and lifecycle management.
Manufacturing solutions are structured to support reliability, regulatory confidence, and sustained product integrity across the full lifecycle of women’s health products. Advance women’s health manufacturing through disciplined production practices designed to maintain quality, compliance, and long-term formulation performance.